---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-23-002040"
form_type: "8-K"
ticker: "SNGX"
cik: "0000812796"
company_name: "SOLIGENIX, INC."
filed_at: "2023-02-24T23:59:59+00:00"
generated_at: "2026-06-19T01:04:36.538521+00:00"
event_type: "regulatory"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Nasdaq grants Soligenix continued listing subject to stockholders' equity compliance by March 31, 2023

## Summary
- Nasdaq granted continued listing conditional on meeting minimum bid price by Feb 24 and stockholders' equity by March 31, 2023.
- Soligenix satisfied the bid price condition as of Feb 24, 2023 (closing bid >= $1.00 for 10 consecutive sessions).
- Company must demonstrate compliance with $2.5M stockholders' equity requirement by March 31, 2023; no assurance of success.
- Original delisting notice (Dec 20, 2022) cited failure of both minimum bid price and stockholders' equity rules.
- Hearing was held Feb 2, 2023; Panel granted extension with conditions.

## SEC filing metadata
- accession: 0001558370-23-002040
- form_type: 8-K
- ticker: SNGX
- cik: 0000812796
- company_name: SOLIGENIX, INC.
- filed_at: 2023-02-24T23:59:59+00:00
- event_type: regulatory
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/812796/000155837023002040/0001558370-23-002040-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/812796/000155837023002040/sngx-20230221x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-23-002040
- JSON: https://secwatch.observer/filing/0001558370-23-002040.json
- Plain text: https://secwatch.observer/filing/0001558370-23-002040.txt

## Key facts
- Listing & Compliance Notices
  SOLIGENIX, INC. received a nasdaq extension granted notice regarding stockholders equity (rules 5550(b)(1)).
  - Exchange: nasdaq
  - Notice: extension granted
  - Deficiency: stockholders equity
  - Rules: 5550(b)(1)
  source text: February 21, 2023, the Company received a letter (the “Continued Listing Letter”) from Nasdaq, stating that the Panel granted the Company’s request to continue its listing on Nasdaq, on the condition that (1) on February 24, 2023, the Company shall have demonstrated compliance with the Minimum Bid Price Requirement, by evidencing a closing bid price of $1.00 or more per share for a minimum of ten consecutive trading sessions; and (2) on or before March 31, 2023, the Company shall demonstrate compliance with the Stockholders’ Equity Requirement. The Continued Listing Letter is consistent with
  evidence_url: https://www.sec.gov/Archives/edgar/data/812796/000155837023002040/0001558370-23-002040-index.htm
- Listing & Compliance Notices
  SOLIGENIX, INC. received a nasdaq extension granted notice regarding minimum bid price (rules 5450(a)(1)).
  - Exchange: nasdaq
  - Notice: extension granted
  - Deficiency: minimum bid price
  - Rules: 5450(a)(1)
  source text: February 21, 2023, the Company received a letter (the “Continued Listing Letter”) from Nasdaq, stating that the Panel granted the Company’s request to continue its listing on Nasdaq, on the condition that (1) on February 24, 2023, the Company shall have demonstrated compliance with the Minimum Bid Price Requirement, by evidencing a closing bid price of $1.00 or more per share for a minimum of ten consecutive trading sessions; and (2) on or before March 31, 2023, the Company shall demonstrate compliance with the Stockholders’ Equity Requirement. The Continued Listing Letter is consistent with
  evidence_url: https://www.sec.gov/Archives/edgar/data/812796/000155837023002040/0001558370-23-002040-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.